Diflunisal Cancer Therapy

This innovative new approach to treatment makes it possible to target the cancer cells of tumors and metastases. It is based on the widespread knowledge that tumors and metastases have acidic environments. This quality makes it possible to selectively target cancer cells using pH-sensitive substances. This is where combinations of various derivatives of salicylic acid come into play. Almost all of the substances used are licensed medicines for the treatment of other diseases. The usual side effects of chemotherapy should not be expected.

Experiments have shown that these substances trigger cell death (apoptosis) and pore formation in the membranes of cancer cells.

The substances used in this new therapy that have been identified as active are Diflu, a derivative of salicylic acid and a licensed anti-inflammatory drug.

Diflu’s characteristic properties are reinforced by the adjuvant administration of a second substance that produces a synergetic effect. This ancillary function is performed by two other salicylates that are also licensed medications: ASA (Aspirin) and PAS, a drug used to treat tuberculosis. The active drug therefore consists of combinations of Diflu and either ASA or PAS, working in synergy.

The Diflu-Treatment is a new therapy that uses an active substance derived from salicylic acid called Diflunisal. This new treatment combats cancerous solid-state tumors and metastases that occur in an acidic extracellular environment (including stage 3 and 4 cancers). Another new drug – Atu027 – can also be used to attack the lymphatic vessels of the tumor and help prevent the development of metastasis. The Diflu-treatment opens up the opportunity to selectively target cancer cells using the licensed medications, while withholding the same side effects experienced with chemotherapy.

What to Expect Cancer diseases and tumors develop differently and every patient’s case is unique. But all cases of cancer illnesses have something in common: the earlier the cancer is detected, the better the chances of curing it.

Before the Diflu-treatment is started, each patient is evaluated to better understand the corrective approach needed for their particular case through diagnostics and micronutrients.Upon a decision as to what treatment best suits a patient’s needs, that treatment will commence.

With Diflu, the treatment will attack the cancerous cells specifically while leaving the healthy surrounding cells unaffected. This procedure will do the least amount of damage to a person’s body, but remain effective at attacking the cancer in an effort to eliminate it. In order to mitigate side effects, complementary cancer therapies are used. The healthcare facilities which administer the treatment take a holistic approach with this treatment. The micronutrient program helps prevent deficiencies, and the treatment of magnetic fluid hyperthermia strengthens the body’s resilience. Physical therapies will help you regain your strength and endurance. The psycho-oncological support helps regain your joy of life and engage your mind in the healing process. Sinerge, in partnership with a leading edge hospital in Germany, is your gateway to the Diflu-treatment and the opportunity to beat cancer no matter the stage you are in.

Sinerge, no matter which stage of cancer, tooth for you to receive therapy and treatment in Germany UNIFONTIS you in your negotiations with the bridge will be.

AMT chamomile extract therapy
The precursor chemical AMT has been used in a range of studies around the world, and shows promise with respect to its impact on quality of life and its anti-tumor properties. Following a critical analysis, the modified chamomile extract can be used in the curative treatment of patients.

Heat (for example generated using ultrasound or electromagnetic waves) warms the tumor tissue, putting it under stress. Tumor cells no longer receive the supplies they need. This supports the effects of chemotherapy and radiotherapy. Rather than targeting the tumor tissue directly, the aim is to slow the natural depletion of chemotherapy and radiotherapy. We also engage partner companies to administer hyperthermia treatment.

Virus treatment in oncology
In special situations we use anti-viral drugs to enhance the effectiveness of other anti-tumor treatments such as chemotherapy. Another option is oncolytic virotherapy. This is an increasingly significant treatment method that utilizes replicating viruses to destroy cancer cells. The latest findings in this field relate to the feasibility of administering virotherapy in a single session, identifying substances that promote the spread of the virus within the tumor, maximizing efficacy and dosage.

Other Therapies